Oral Glucose Tolerance Test and Post Partum Diagnosis of Diabetes Mellitus, Type 2 (DT2 Post-Partum)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03644004|
Recruitment Status : Not yet recruiting
First Posted : August 23, 2018
Last Update Posted : August 24, 2018
Diabetes mellitus, type 2, is a chronic disease which can be linked with many complications in connexion with impaired blood glucose balance.
It diagnosis in risky subjects such as in patients with medical history of gestational diabetes is therefore imperative to prevent its complications.
Actual guidelines recommend an oral tolerance glucose test, measuring glucose levels after oral glucose intake (75g), between 6 an 12 weeks after childbirth. But studies reveal a low diagnosis rate.
The study of the current practices of diagnosis methods seem to be essential in order to improve this diagnosis.
|Condition or disease||Intervention/treatment|
|Gestational Diabetes||Other: frequency of diabetes mellitus, type 2, diagnosis in patients with medical history of gestational diabetes.|
|Study Type :||Observational|
|Estimated Enrollment :||150 participants|
|Official Title:||Descriptive Study of the Diabetes Mellitus, Type 2 Diagnosis Methods During Postpartum Period in Patients With Medical History of Gestational Diabetes Whom Benefited an Educational Therapy Session.|
|Estimated Study Start Date :||October 2018|
|Estimated Primary Completion Date :||April 2019|
|Estimated Study Completion Date :||April 2019|
Women with medical history of gestational diabetes
Patients followed at the hospital of Vienne for gestational diabetes in 2016.
Other: frequency of diabetes mellitus, type 2, diagnosis in patients with medical history of gestational diabetes.
Patients will be contacted by mail with sending of the information notice to ask them to participate in the study.
If they don't reply, the subjects will be called by phone by the investigator to collect their non opposition of participation at the study.
During this call, the investigator will be able to answer all the questions about the study.
The report of this telephone conversation will be register in the medical file of the patient.
Then, we will collect informatic data from the hospital concerning the patients.
After that they will be contacted by phone to answer a survey. Beside, another secure survey will be send by email to each patient's family doctor.
To finish, crossing data between those of the patients and the family doctor and anonymisation of the data.
Other Name: Evaluate the frequency of diabetes mellitus, type 2, diagnosis with an oral glucose tolerance test between 6 and 12 weeks after childbirth in patients with medical history of gestational diabetes.
- Performing oral glucose tolerance test in order to detect type 2 diabetes [ Time Frame: Month 6 ]Performing oral glucose tolerance test between 6 and 12 weeks after childbirth. As recommended by actual World Health Organisation (WHO) guidelines
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03644004
|Contact: Laura BOGENMANN, MD||04.74.31.66.82 ext +email@example.com|
|Contact: Arthur PETILLOT||06.37.11.31.21 ext +firstname.lastname@example.org|
|Centre hospitalier Lucien Hussel||Not yet recruiting|
|Contact: Arthur PETILLOT 06.37.11.31.21 ext +33 email@example.com|
|Contact: Sophie MISSOL 06.46.10.41.49 ext +33 firstname.lastname@example.org|
|Principal Investigator: Laura BOGENMANN, MD|
|Study Director:||Laura BOGENMANN, MD||Centre Hospitalier de Vienne|